% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

  • afewminutes21 afewminutes21 Dec 19, 2013 10:10 PM Flag

    Geron and Boardwalk Empire

    Gaston Means to undercover FBI agent Tolliver in a recent episode of "Boardwalk Empire": "The best predictor of future behavior is past behavior." John Chip Scarlett's past behavior:

    Sensus Drug Development Corportion
    1992 – 2001 Austin, TX
    As Founder and CEO, led the Company through a key partnership with Genentech, the acquisition, development and approval of an endocrine product, SOMAVERT® (pegvisomant), and the sale of the Company to Pharmacia in 2001.

    Covance Biotechnology Services, Inc.
    1993 – 2001 Research Triangle Park, NC
    Founder & Director - Developed the business plan and negotiated a joint venture with Corning, Inc., directed site selection and construction of a state-of-the-art, process development and recombinant protein cGMP manufacturing facility in RTP, and as a Director, provided Board oversight for a 450 employee business with multiple large pharmaceutical company clients prior to its sale to Akzo Nobel’s Diosynth Division in 2001.

    Tercica, Inc.
    2001 – 2008 Brisbane, CA
    As Co-Founder and CEO, led the Company through the acquisition, approval and commercialization of two novel endocrine products (INCRELEX® and SOMATULINE® DEPOT), key partnerships with Genentech and Ipsen S.A., and multiple financing rounds including the IPO in 2004 and subsequent follow-on equity offerings. Tercica merged with Ipsen in the 4th quarter of 2008 in a transaction that valued the company at approximately $660 million.

    Proteolix, Inc.
    2009 – 2010 South San Francisco, CA
    As President and CEO led Proteolix, a biotechnology company developing proteasome inhibitors (including carfilzomib) for oncology and immunology applications, through a management realignment and subsequent merger with Onyx Pharmaceuticals (NASDAQ: ONXX) valued at $856 million.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ....well you certainly dug up the CV goods on Chippy. That guy reads like a used pharma salesman in a white polyester lab coat. So it's a buyout again.
      Now for the secondary that apparently wasn't exercised recently in that 100mil share turnover game. Wonder if that had anything to do with a potential buyer? INCY must be getting antsy. Maybe the shelf is GERN's poison pill threat to stop any hostile takeovers

2.20-0.07(-3.08%)Sep 29 4:00 PMEDT